Biosimilars – a risky bet?
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)
Published: 20 Mar-2009
DOI: 10.3833/pdr.v2009.i3.1080 ISSN: 1756-7874
Section: Editorial
Fulltext:
Abstract
The market for biosimilars will increase as more biologic drugs reach patent expiry within the next 10 years...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
RSS